New imaging software improves lung diagnosis for 30% of patients who can't tolerate contrast dye; has added diagnostic benefits for all patients
Southfield, Mich., May 17, 2024 – For up to 30% of patients who are allergic to medical contrast dye or have a dye restriction because of other health conditions, they might find that it takes longer to get a diagnosis when it comes to life-threatening lung issues such as pulmonary embolism. That's because imaging methods that detect lung problems but don't use contrast dye aren't as accurate and can be more time-consuming to administer.
Now, new imaging software, developed by pulmonologist Girish Nair, M.D., with Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, and biomedical ...















